Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial

BACKGROUND: The effects of convalescent plasma (CP) therapy in hospitalised patients with coronavirus disease 2019 (COVID-19) remain uncertain. This study investigates the effect of CP on clinical improvement in these patients. METHODS: This is an investigator-initiated, randomised, parallel arm, op...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekine, Leo, Arns, Beatriz, Fabro, Bruna R., Cipolatt, Murillo M., Machado, Rafael R.G., Durigon, Edison L., Parolo, Edino, Pellegrini, José Augusto S., Viana, Marina V., Schwarz, Patrícia, Lisboa, Thiago C., Dora, José Miguel S., Portich, Julia P., Paz, Alessandra A., Silla, Lucia, Balsan, Almeri M., Schirmer, Felipe da-Silva, Franz, Juliana P.M., da-Silveira, Luciana M., Breunig, Raquel C., Petersen, Viviana, Sosnoski, Monalisa, Mesquita, Nanci F., Volpato, Fabiana Caroline Z., Sganzerla, Daniel, Falavigna, Maicon, Rosa, Regis G., Zavascki, Alexandre P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287736/
https://www.ncbi.nlm.nih.gov/pubmed/34244316
http://dx.doi.org/10.1183/13993003.01471-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287736/
https://www.ncbi.nlm.nih.gov/pubmed/34244316
http://dx.doi.org/10.1183/13993003.01471-2021

Ejemplares similares